Introducing 

Prezi AI.

Your new presentation assistant.

Refine, enhance, and tailor your content, source relevant images, and edit visuals quicker than ever before.

Loading…
Transcript

Pharmacology

  • Greater lipophilicity

  • Different mechanism

  • Specific binding contributing to 12 hours of duration

  • Guinea Pig models

  • Significant inhibition in inflammatory mediator release

SALMETEROL

Structural Activity Relationship

Conclusion

  • Bulk on nitrogen increases Beta receptor activity

Amino group:

  • essential for direct activity

  • Must be separated by 2 carbon atoms.

  • Meta-hydroxy group replaced by methyl hydroxy gives good Beta 2 receptor selectivity

  • First treatment was 100 years ago

  • Earlier non selective beta agonists (isoprenaline & epinephrine) were used

  • Target identification of beta 2 receptor led to discovery of Salbutamol & later Salmeterol

  • The phenyl alkyl side chain is responsible for the long 12 hours of activity

  • Binding to exosite and high lipophylicity (different mechanism )

  • It's not a first line treatment but preferred as a combination drug

History of Asthma

  • Asthma?
  • Causes of Asthma: environmental, occupational and genetic
  • Triggering Factors: dust, fumes, pollens, pet dander
  • Heavy Exercise & Stress

Drugs used:

  • Inhaled corticosteroids, ex: flunisolide
  • Long acting beta 2 agonist, salmeterol

  • Combination inhalers, fluticasone-salmeterol
  • Short acting beta2 agonist, salbutamol

Synthesis of Salmeterol

  • Asymmetric borane reduction – oxazaborolidine and borane

Target Identification

References

1. Docherty JR. The pharmacology of . Pharmacol . 1989;337(Suppl. 12):118–284.

2. Clinic M. Asthma - Mayo Clinic. 2015.

3. CDC - Asthma - Asthma Control Publications.

4. Overview - COPD - Mayo Clinic.

5. Marasco C. Chemical & Engineering News: Top Pharmaceuticals: Salbutamol.

American Chemical Society . 2005.

6. Coleman R. On the mechanism of the persistent action of salmeterol: what is the current

position? Br Pharmacol Soc . 2009;(158):180–2.

7. Page C, Humphrey P. Sir David Jack: an extraordinary drug discoverer and developer. Br

J Clin Pharmacol. 2013 May;75(5):1213–8.

8. Chavan SP, Garai S, Dutta AK, Pal S. Friedel-crafts acylation reactions using esters.

European J Org Chem. 2012;

9. Casitas A, Ribas X. Aromatic/Vinylic Finkelstein Reaction. In: Copper-Mediated Cross-

Coupling Reactions. Hoboken, NJ, USA: John Wiley & Sons, Inc.; 2013. p. 239–51.

10. Wakeham RJ, Taylor JE, Bull SD, Morris JA, Williams JMJ. Iodide as an activating agent

for acid chlorides in acylation reactions. Org Lett. 2013;

11. European Search Report - EP 13 15 4981. Munich; 2013. p. 4.

12. Hett R, Stare R, Helquist P. Enantioselective synthesis of salmeterol via asymmetric

borane reduction. Tetrahedron Lett. 1994;

13. John H. Block JMB. Wilson and Gisvold’s Textbook of Organic and Medicinal

Pharmaceutical Chemistry. Eleventh E. Troy DB, editor. 2004 Lippincott Williams &

Wilkins;

14. Kummer F, editor. Treatment of Asthma: The long-acting beta-2-agonists. Vienna:

Springer Vienna; 1998.

15. Lötvall J. Pharmacology of bronchodilators used in the treatment of COPD. Respir Med.

2000;94:S6–10.

16. Ricciardolo FLM, Nijkamp F, De Rose V, Folkerts G. The Guinea pig as an animal model

for asthma. Curr Drug Targets. 2008;9(6):452–65.

(Serevent)

By: Kavya Cukkemane, Akshit Jaiswal, Zacharias Olsen, Aðalbjörg Þorkelsdóttir, Gloria Singla

Learn more about creating dynamic, engaging presentations with Prezi